RxDoctor Payments Data

Todd Stachowiak, PA

Physician Assistant · Marysville, MINPI 1831166768

Payments from drug & device makers

$12,610in general payments, 2019–2025

Across 807 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$587
  • Amgen$464
  • plus $6K from 53 others

What the payments were for

  • Food & beverage$12,610100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)99$2,194
AbbVie145$1,719
Novo Nordisk88$1,066
Lilly USA, LLC94$1,055
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)28$587
Amgen35$464
Vanda Pharmaceuticals Inc.15$398
GSK26$369
Bayer24$357
Otsuka America Pharmaceutical, Inc.18$318
Boehringer Ingelheim17$301
Johnson & Johnson28$266
Axsome Therapeutics, Inc.8$237
Alkermes, Inc.8$207
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$201
Teva Pharmaceuticals USA, Inc.13$197
QOL Medical, LLC12$189
Antares Pharma, Inc.10$183
Biohaven Pharmaceuticals, Inc.10$162
Amarin Pharma, Inc.9$152
Biohaven Pharmaceutical Holding Company Ltd.9$149
Novartis8$141
Astellas Pharma US Inc7$106
Merck7$106
Takeda Pharmaceuticals U.S.A., Inc.6$105
Scilex Pharmaceuticals Inc.4$92
Sanofi-aventis U.S. LLC5$89
Biogen4$81
Paratek Pharmaceuticals, Inc.4$76
Medtronic1$69
Abbott4$69
Grifols USA, LLC3$67
Mylan Specialty L.p.4$65
Phathom Pharmaceuticals, Inc.3$61
Exact Sciences4$59
E.r. Squibb & Sons, L.L.C.4$54
Pfizer3$53
Corcept Therapeutics2$52
Esperion Therapeutics, Inc.3$51
Halozyme Inc2$41
Jazz Pharmaceuticals Inc.2$35
Seqirus USA Inc2$34
Verity Pharmaceuticals Inc.1$28
Tolmar, Inc.2$28
ANI Pharmaceuticals, Inc.1$25
Otsuka Pharmaceutical Development & Commercialization, Inc.1$25
Sanofi Pasteur Inc.1$24
Avanir Pharmaceuticals, Inc.1$24
Endo Pharmaceuticals Inc.1$21
Dexcom, Inc.1$20
Neurocrine Biosciences, Inc.1$18
Sumitomo Pharma America, Inc.1$18
Lundbeck LLC1$17
Idorsia Pharmaceuticals US Inc1$16
Zealand Pharma US, Inc.1$15
Almatica Pharma LLC1$14
Supernus Pharmaceuticals, Inc.1$14
Upsher-smith Laboratories LLC1$14
Arbor Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,610 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$55,934
Medicare patients
221
Services billed
919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$68,035
MounjaroTirzepatide49$56,707
JardianceEmpagliflozin35$45,785
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$36,267
FarxigaDapagliflozin Propanediol28$35,056
EliquisApixaban23$30,827
JanuviaSitagliptin Phosphate31$21,406
Oxymorphone Hcl ErOxymorphone Hcl12$20,133
JubliaEfinaconazole14$18,835
Advair HfaFluticasone Propion/Salmeterol16$10,927
TrulicityDulaglutide11$9,883
MyrbetriqMirabegron14$9,639
Victoza 3-PakLiraglutide12$9,252
Breo ElliptaFluticasone/Vilanterol14$6,823
Fluticasone-SalmeterolFluticasone Propion/Salmeterol38$6,682

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,066$68,03544 claims
Lilly USA, LLCMounjaro, Trulicity$1,055$66,59060 claims
Boehringer IngelheimJardiance$301$45,78535 claims
GSKTrelegy Ellipta, Breo Ellipta$369$43,09065 claims
AstraZenecaFarxiga$2,194$35,05628 claims
PfizerEliquis$53$30,82723 claims
MerckJanuvia$106$21,40631 claims
Astellas Pharma US IncMyrbetriq$106$9,63914 claims
AbbVieSynthroid$1,719$1,16614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Marysville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →